Alliance for Reducing Microbial Resistance

EU Legislative Interests

General Pharmaceutical Legislation Revision, Critical Medicines Act, Biotech Act, Multiyear Financial Framework, Start-up and Scale-up Strategy and other proposals around antimicrobial development and access.

Communication Activities

ARMoR is involved with discussing concepts around antimicrobial resistance with various actors across EU institutions, industry, NGOs and global health organisations. We publish position papers and research around our asks to EU institutions and member states on this blog (https://www.armoramr.org/blog). We may also hold events related to antimicrobial R&D, incentives and access within institutional premises, alongside relevant co-sponsors. Our current focus in the EU involves the establishment of an improved antimicrobial R&D ecosystem and market to ensure wide access to antimicrobials capable of treating drug resistant infections, both in the EU and globally.

Interests Represented

Does not represent commercial interests

Member Of

ARMoR is a member of the AMR Stakeholder Network (https://epha.org/amr-stakeholder-network/), the WHO Novel Medicines Platform and the UN Quadripartite Multistakeholder Platform on AMR.

Organisation Members

Our organisation has none of our own members - we are not a membership based organisation. We are associated with the following entities. https://www.charityentrepreneurship.com/ https://www.ppf.org/

Additional Information

ARMoR is was initially funded through a seed grant from https://www.charityentrepreneurship.com/ and intends to raise future funds from global health philanthropy. We have had additional funding through HNWI donors and foundations, with full disclosure of all donors over 10% of our budget.